Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis
Clinical trial NCT04732117 · COMPLETED
Trial details
- NCT number
- NCT04732117
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2024-04-03
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.